These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12141885)

  • 21. Laparoscopic fundoplication compared with medical management for gastro-oesophageal reflux disease: cost effectiveness study.
    Epstein D; Bojke L; Sculpher MJ;
    BMJ; 2009 Jul; 339():b2576. PubMed ID: 19654097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic review: Is there excessive use of proton pump inhibitors in gastro-oesophageal reflux disease?
    Lee TJ; Fennerty MB; Howden CW
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1241-51. PubMed ID: 15606386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PPI use in the OTC era: who to treat, with what, and for how long?
    Inadomi JM; Fendrick AM
    Clin Gastroenterol Hepatol; 2005 Mar; 3(3):208-15. PubMed ID: 15765438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficiency of potent gastric acid inhibition.
    Carballo F
    Drugs; 2005; 65 Suppl 1():105-11. PubMed ID: 16335864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On-demand proton pump inhibitor therapy in patients with gastro-oesophageal reflux disease.
    Pace F; Pallotta S; Bianchi Porro G
    Dig Liver Dis; 2002 Dec; 34(12):870-7. PubMed ID: 12643297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost effectiveness of competing strategies to prevent or treat GORD-related dysphagia.
    Sonnenberg A
    Pharmacoeconomics; 2000 Apr; 17(4):391-401. PubMed ID: 10947494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of gastroesophageal reflux disease.
    Pettit M
    Pharm World Sci; 2005 Dec; 27(6):432-5. PubMed ID: 16341949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical treatment of gastro-oesophageal reflux disease.
    De Giorgi F; Savarese MF; Atteo E; Leone CA; Cuomo R
    Acta Otorhinolaryngol Ital; 2006 Oct; 26(5):276-80. PubMed ID: 17345932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On-demand requirements of patients with endoscopy-negative gastro-oesophageal reflux disease: H2-blocker vs. proton pump inhibitor.
    Juul-Hansen P; Rydning A
    Aliment Pharmacol Ther; 2009 Jan; 29(2):207-12. PubMed ID: 19006541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How do we offer clinical relief to patients with gastro-oesophageal reflux disease?
    Galmiche JP
    Eur J Gastroenterol Hepatol; 2000 Jun; 12 Suppl 1():S3-6. PubMed ID: 10929891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acid suppression in gastro-oesophageal reflux disease: Why? How? How much and when?
    Jones MP
    Postgrad Med J; 2002 Aug; 78(922):465-8. PubMed ID: 12185218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review article: alternative approaches to the long-term management of GERD.
    Fennerty MB
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():39-44. PubMed ID: 16303036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel methods of using proton-pump inhibitors.
    Vakil N
    Gastroenterol Clin North Am; 2002 Dec; 31(4 Suppl):S85-8. PubMed ID: 12489474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Burden of gastro-oesophageal reflux disease in patients with persistent and intense symptoms despite proton pump inhibitor therapy: A post hoc analysis of the 2007 national health and wellness survey.
    Toghanian S; Johnson DA; Stålhammar NO; Zerbib F
    Clin Drug Investig; 2011 Oct; 31(10):703-15. PubMed ID: 21756007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endoluminal therapies for gastro-oesophageal reflux disease.
    Galmiche JP; Bruley des Varannes S
    Lancet; 2003 Mar; 361(9363):1119-21. PubMed ID: 12672327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress with novel pharmacological strategies for gastro-oesophageal reflux disease.
    Tonini M; De Giorgio R; De Ponti F
    Drugs; 2004; 64(4):347-61. PubMed ID: 14969571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intermittent and on-demand use of proton pump inhibitors in the management of symptomatic gastroesophageal reflux disease.
    Bardhan KD
    Am J Gastroenterol; 2003 Mar; 98(3 Suppl):S40-8. PubMed ID: 12644030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Managing gastro-oesophageal reflux disease in primary care.
    Nathoo V
    Int J Clin Pract; 2001 Sep; 55(7):465-9. PubMed ID: 11594257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the cost effectiveness of pharmacotherapy or surgery (laparoscopic fundoplication) in the treatment of GORD.
    Bojke L; Hornby E; Sculpher M;
    Pharmacoeconomics; 2007; 25(10):829-41. PubMed ID: 17887805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical economics review: cost-effectiveness of treatment alternatives for gastro-oesophageal reflux disease.
    Sridhar S; Huang J; O'Brien BJ; Hunt RH
    Aliment Pharmacol Ther; 1996 Dec; 10(6):865-73. PubMed ID: 8971282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.